1. A prospective, randomized, masked, placebo-controlled multisite clinical study of grapiprant, an EP4 prostaglandin receptor antagonist (PRA), in dogs with osteoarthritis;Rausch-Derra L,2016
2. Efficacy and safety of Firocoxib in the management of canine osteoarthritis under field conditions;Hanson PD,2006
3. Zoetis Inc. Freedom of information summary. Rimadyl; carprofen. NADA 141-111. US Food and Drug Administration; 2014.
4. Novartis Animal Health. Freedom of information summary. Deramaxx; deracoxib. NADA 141-203. US Food and Drug Administration; 2011.
5. Care giver placebo effect in dogs with osteoarthritis;Conzemius MG,2012